STOCKS TELEGRAPH

Category: Mid Day Movers

  • Stocks to Watch for Quick Gains This Week

    Stocks to Watch for Quick Gains This Week

    The markets are doing well today, but there are stocks that are doing extraordinarily better than the rest of the market. By following market momentum, one can make good money with these stocks today. Some of the stocks that are gaining incredible momentum this afternoon are as below:

    Oxbridge Re Holdings Ltd [NASDAQ: OXBR]

    This is one of the stocks that have benefited immensely from the increased bullish sentiment in the equity markets.  The stock has seen a massive increase in buying sentiment, and short volumes are on a decline. If this trend continues, OXBR could test $6 today, or within the week.

    It is one of the stock’s that offers investors an opportunity for huge gains this week. So far, it’s up by over 200%, and anyone who got in earlier in the day is in big gains. Since there is no news, the move is purely speculative, and investors need to keep an eye on short action. As long as short volumes remain low, upside momentum is likely to remain dominant.

    Virgin Galactic Holdings Inc [NYSE: SPCE]

    This is another big mover this afternoon and looks set for more gains all through the day and possibly through the week. While there is no specific news about it, this stock, is riding on sentiment by Bank of America analysts that it could double in value. The analysts are counting on the fact that it has a unique market, and that it is well prepared to tackle the needs of this market.

    The analysts have argued that while the business has not yet commenced operations, its potential growth in the space market is limitless. This validation has seen investor interest in this stock grow. As excitement around this stock grows, shorts could decline and see its value rally to new highs within the week. It’s an interesting stock to watch for investors chasing massive gains in a short time.

    Uber [NYSE: UBER]

    Uber is another interesting stock to watch today, and all through the week. While the stock has not yet pumped, there is potential that it could start recording massive gains. This follows news that the company had been given the green light to continue operating in London.

    London is one of the largest markets for cab-hailing services and being denied the license was a huge blow to the company. As this news filters into the market, the stock is likely to record major gains short-term.

     

     

  • SG Blocks Inc [SGBX] Rallies after LAX COVID-19 Test Centers Deal

    SG Blocks Inc [SGBX] Rallies after LAX COVID-19 Test Centers Deal

    SG Blocks Inc [NASDAQ: SGBX] is quite strong this Friday and is up by over 40% at the time of writing. This follows the company’s announcement that it was planning to build a modular COVID-19 testing centre for LAX. The company expects to have it done by the 1st of November 2020. The company stated that the test pods will include CLIA certified labs, and will also have the OSANG GeneFinder™ test that will allow it to give clients results in under 2 hours.

    The company further stated that the tests would be made with a partnership with Grimshaw. The most interesting aspect to the test pods is that they will be made using disused shipping containers, making them both safe and environmentally friendly. On top of that, the labs will have staff from Clarity Mobile Venture, which is a joint operation between Clarity Labs and SG Blocks.

    Commenting on the deal, SG Blocks CEO Paul Galvin stated that they are happy to be working with LAX in the quest to make air travel safe. He added that with COVID-19 becoming the new normal, accessibility of rapid testing was becoming essential. He added that the company was able to offer both services using its D-Tec testing pods, and Turnkey D-Tec. On his part, Grimshaw Chairman Andrew Whalley stated that the D-Tec system was flexible and allowed for a fully operational lab to be used at the exact locations where samples are needed.

    The LAX deal deepens the market presence of SG Blocks Inc as a world-class leader in the development of use-of-code engineered shipping containers, that are safe to use and environmentally sustainable. This is likely to drive the demand for its products both now and in the long run.

    One key aspect to the market that could see it record exponential growth is the ever-increasing challenge of the COVID-19 pandemic. Until a vaccine is found and widely deployed, testing remains one of the best ways to control the spread of the pandemic. In essence, with the LAX deal in position, the company is in pole position to land similar deals with other airports and company installations. This could see the company grow revenues grow to new heights in the near-term and see an increase in its stock price in the near-term. This makes it one of the high potential stocks to keep an eye on in the near-term.

    About SG Blocks Inc

    SG Blocks Inc is a container design and fabrications company.  It is based in Brooklyn, New York.

     

  • Tesla (NASDAQ: TSLA) Claims Nikola Steal Its Truck Design

    Tesla (NASDAQ: TSLA) Claims Nikola Steal Its Truck Design

    Tesla Inc. (NASDAQ: TSLA) revealed that Nikola Corporation ()NASDAQ: NKLA) has copied the truck design of Tesla from Adriano Mudri, a director of design at the automotive company. Nikola Corporation is in a legal battle with Tesla Inc. as it earlier claimed that Tesla has copied the design of the Nikola One concept. But now the electric car maker is striking back the Nikola Corporation and filed a lawsuit in the US district court.

    Nikola Corporation has earlier obtained the patent for the design of a few features of its Nikola Truck it has launched in 2016, a year before Tesla has revealed its own electric truck.  Nikola is demanding $2 billion in damages from Tesla. But Tesla denied the claim and said that the patent which Nikola has obtained is not valid as it is failed to reveal that some of the Nikola One’s features were designed by Adriano Mudri.

    The electric car maker has issued the statement and revealed that the Adriano Mudri is the designer of the Road Runner concept trucks which is a hydrogen-power concept truck. Tesla said that Trevor Milton has contacted Adriano Mudri during 2014 and or /2015 and he was aware of the design of the roadrunner truck which has similar features as Nikola one.

    Tesla argued that Trevor Milton has deceiving intent in not naming Mudri as an inventor in the patent application. The company also claimed that the patent office wouldn’t have issued the patent if they would have been aware that some features were based on a prior design by Mudri.

    Shares of Tesla Inc. (NASDAQ: TSLA) went up 1.95% at $387.79 during the trading session of Thursday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low range of $43.67 and a high range of $502.49. It has moved up 787.96% from its 52-weeks low and moved down -22.83% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.20. Tesla Inc. has a total market capitalization of $346.05 billion at the time of writing.

    Earlier, Hindenburg’s research has also claimed in a report that Nikola Corporation has made a series of false public statements. The research report also claimed that the company has deceived the public with the video called ‘Nikola One in Motion.’ But the Nikola Corporation has denied the accusation. Furthermore,  CEO Trevor Milton has also resigned from his position to defend himself against the claim made by Hindenburg research.

  • Why Net Element Inc [NETE] is The Stock to Watch over the Next Decade

    Why Net Element Inc [NETE] is The Stock to Watch over the Next Decade

    Net Element Inc [NASDAQ:NETE] is in breakout this afternoon. Though it is still volatile at the moment, today’s price move has seen it clear the losses from the last two months. The huge bullish reversal move follows the company’s announcement that Mullen, an electric car company that it recently announced a merger with was launching an electric car manufacturing facility.

    The pilot facility is for the assembly of the MX-05, an electric SUV that will be completed in April next year.  Mullen also announced that customers can start taking pre-orders for the SUV, and they would start at a price of $55k. The two companies recently merged in an all-stock deal that would see Mullen’s investors get the majority of the outstanding shares.

    The deal is huge for Net Element investors because it means they stand to benefit from the huge value increase that will come with the sale of the MX-05. Mullen has already announced that it would start taking pre-orders for the SUV on 1st October this year.

    The company has also announced it would start the transformation of its California-based research and development facility into a state-of-the-art facility for the SUVs. The upgrade is expected to start in October as well. According to Mullen CEO David Michery, the company was happy to start the construction of the pilot facility and also start taking pre-orders for its electric SUV.

    He added that the vehicles would be for homologation that that would take 16 months and get completed in May of 2022 when the company expects to start selling its first vehicle to the public.

    Besides, the excitement that often comes with such news, Mullen’s plans for an electric SUV stands to benefit both Mullen and NETE element investors in the long run, and it stands to reflect in the stock price. That’s because the demand for EV’s stands to grow as governments continue to make favourable policies.

    Yesterday, the Governor of California stated that the State intended to ban the sale of emitting cars by the year 2035. Automatically, this means that the demand for electric vehicles is set to keep growing over the next decade. Companies like Mullen that are already taking steps in this direction are likely to grow market share and revenues and peak as the ban on fossil fuel energy takes effect.

    About Net Element Inc

    Net Element Inc is a financial technologies company. It is headquartered in Miami Beach, Florida.

  • ASLAN Pharmaceuticals (NASDAQ: ASLN) Starts ASLAN004 Atopic Dermatitis Study

    ASLAN Pharmaceuticals (NASDAQ: ASLN) Starts ASLAN004 Atopic Dermatitis Study

    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) has commenced the multiple ascending dose (MAD) study testing the first-in-class therapeutic antibody ASLAN004 in moderate to severe atopic dermatitis (AD) patients. The company has also opened clinical sites in the US and Australia and also starting enrolling patients. The patients will now enroll from 3 sites in the US, 4 sites in Australia, and 2 existing sites in Singapore.

    ASLAN004 is a first-in-class monoclonal antibody that combines with the IL-13 receptor α1 subunit (IL-13Rα1). It also blocked the signaling of two pro-inflammatory cytokines, IL-4 and IL-13. These cytokines are central to activate symptoms of AD, such as redness and itching of the skin.

    ASLAN Pharmaceuticals has recently started the enrollment in the second cohort of double-blind, placebo-controlled studies in Singapore after the government has lifted the coronavirus restrictions. All 8 patients have been enrolled in the cohort and the company is planning to start enrollment into the third cohort after approval by the Data Monitoring Committee.

    Furthermore, 8 patients will be enrolled in Singapore, the US, and Australia. ASLAN expects to report interim, unblinded data from all 3 dose cohorts in 4Q 2020.

    ASLAN Pharmaceuticals, Inc. (NASDAQ: ASLN) shares were trading up 15.71% at $1.92 at the time of writing on Wednesday.

    ASLAN Pharmaceuticals, Inc. share price went from a low point around $0.35 to briefly over $8.18 in the past 52 weeks, though shares have since pulled back to $1.92. ASLAN market cap has remained high, hitting 72.40 Million at the time of writing.

    The company has earlier participated in H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020.

     

  • Carvana (NYSE: CVNA) Stock Is Soaring. Here’s Why.

    Carvana (NYSE: CVNA) Stock Is Soaring. Here’s Why.

    Carvana Co. (NYSE: CVNA) revealed that it has decided to offer up to $1.0 billion in aggregate principal amount of Senior Notes, including $500,000,000 aggregate principal amount of Senior Notes due 2025 and $500,000,000 aggregate principal amount of Senior Notes due 2028. These Senior Notes would be based on certain market conditions and other factors.

    The company is planning to use a portion of the profit from these offerings to redeem in full $600 million aggregate principal amount of its outstanding 8.875% of Senior Notes which are due in 2023.  Carvana has decided to use the remaining net profit to pay expenses and for many other business purposes.

    The leading e-commerce platform for buying and selling used cars has also revealed that the notes will not be registered under the Securities Exchange Act of 1933 and will not be sold or offered to any person without registration or those who are not qualified to buy these notes. These notes will only be offered to those qualified buyers who fulfilled the requirements in accordance with Rule 144A.

    Carvana Co. has also announced that it is foreseeing a record-breaking performance in Q3 2020 in various metrics including Total revenue, Retail units sold, Total gross profit per unit, and EBITDA margin. The company said that the momentum it saw in Q2 also accelerated into the Q3. Carvana saw a record-breaking performance in 2020 and provides the best experience to its customer and adopt all changes which 2020 brought in its business.

    Carvana Co. (NYSE: CVNA) shares went up 30.61% as it gained +53.16 during the trading session of Tuesday. In the past 52-weeks of trading, this company stock has fluctuated between the low range of $22.16 and a high range of $235.00. It has traded up 923.60% from its 52-weeks low and traded down -3.48% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 4.20. This company market capitalization has remained high, hitting $39.09 billion at the time of writing.

     

     

  • Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    NanoVibronix Inc [NASDAQ: NAOV] is on a roll this morning. The stock started gaining upside momentum pre-market when it gained by over 80%, and it’s not easing up. The stock’s upside momentum started after the company announced that the U.S FDA had given it the authorization to sell UroShield® in the U.S market. The FDA stated that UroShield® can apply the Intended Use Code 081.006: Enforcement Discretion Per Final Guidance. It can also use the FDA Product code QMK.

    The FDA authorization has opened the way for the company to start shipping UroShield® to the U.S during the COVID-19 pandemic. This effectively opens up the company’s market at a time when a product like UroShield® is needed in the market.  That’s because, by design, it helps prevent incidents of CAUTI in people suffering from ailments that need the long-term use of indwelling catheters.

    UroShield® achieves this because it is ultrasound-based, which means it is uniquely positioned to stop the buildup of bacteria on urinary catheters that are put inside. By its design, it helps cut on the possibility of catheter-related urinary tract infections, while also cutting on the possibility of CAUTI incidence in people that need long-term catheterization.

    Commenting on the breakthrough, CEO Brian Murphy stated that the FDA continued to carry out its mandate of protecting the public through various means that include shortening the time needed to review new medical devices that are beneficial to the public during the COVID-19 period.   He added that it is on this basis that the FDA approved UroShield® for its ability to lower urinary tract infections. The CEO also touched on the uniqueness of the product stating that at the moment, the company was not aware of any other devices that have the ability to avoid catheter-linked urinary tract infections with the same level of efficiency as UroShield®.

    From an investor perspective, the approval of UroShield® is a big deal for this stock’s value. That’s because it offers the company a foothold in one of the largest markets in the world.  Demand in the U.S is likely to be driven up by COVID-19 has led to an increase in people that need catheterization and the fact that UroShield® has no close competitors in the U.S. This points to higher revenues in the short-term, and a significant increase in the company’s intrinsic value.

    About NanoVibronix Inc

    NanoVibronix Inc makes and sells non-invasive devices that help prevent biofilm, and in pain therapy. It is headquartered in Elmsford, New York.

  • Roku Inc. (NASDAQ: ROKU) Announces Peacock Addition To Its Lineup

    Roku Inc. (NASDAQ: ROKU) Announces Peacock Addition To Its Lineup

    Shares of Roku Inc. (NASDAQ: ROKU) went up 17.67% after it gains +28.35 during the trading session of Monday. The strong performance of the company has shown the positive sentiments of investors after it has added NBC’s Peacock streaming service to the Roku Platform.

    Peacock which was launched by NBC back in July created a hype in the market and has been available to all the platforms except Roku. It has offered a free version where users can access free content alongside paid content which is the main reason for its huge demand.

    Roku Inc. has delayed the addition of Peacock on its platform because of its lengthy negotiation with NBC. The companies were in talks regarding the revenue sharing issue. But finally, they signed an agreement and both the companies are positive that this agreement will support the mutual benefits. Peacock will give access to more than 20,000 hours of on-demand movies and shows as well as news and sports programming.

    Roku Inc. (NASDAQ: ROKU) share price went from a low point around $58.22 to briefly over $185.44 in the past 52 weeks, though shares have since pulled back to $188.82. Roku Inc’s market cap has remained high, hitting $24.16 billion at the time of writing. If we look at its profitability, it has return on assets, investment, and equity of -9.60%, -8.00%, and -19.40%, respectively. This company has a current ratio of 3.10.

    Users can access everything on Peacock as it has offered ‘Peacock Premium’ which is available for $4.99 per month. Viewers may also upgrade Peacock Premium to an ad-free tier for an additional $5.00 per month. The companies have not disclosed the financial considerations yet.

    Analysts said that this deal has helped the company to grow further as Roku has added Peacock before its rival which provides its benefits on future deals with the other streamers. Roku is considered to be a popular platform with amazing content. This showed that its bargaining power has also increased with the increase in its popularity. This is the reason the entertainment company has delayed the addition of Peacock to its lineup.

  • Onconova Therapeutics Inc [ONTX] Set for Gains on 0N 1232300 Trials

    Onconova Therapeutics Inc [ONTX] Set for Gains on 0N 1232300 Trials

    Onconova Therapeutics Inc [NASDAQ:ONTX] is one of the most interesting stocks to watch today. This follows the company’s announcement that it has initiated a phase 1 clinical trial of ON 123300. The trial will be done in China and will be a partnership with HanX Biopharmaceuticals.

    ON 123300 is a new small molecule, and double inhibitor of CD4/6, which is a major enzyme that controls cell energy homeostasis. ON 123300 has been shown to have single-agent toxicity and effectiveness against a wide array of cancers when tested in pre-clinical studies.

    Some of the cancers that it has shown the potential to fight include colon cancer, breast cancer, multiple myeloma, and mantle cell lymphoma.

    The company has been collaborating with HanX since December 2017 in a deal that covers the development, registration and sale of ON 123300 in the Chinese market. Onconova will hold rights for the development and sale of this treatment to the rest of the world.

    Commenting on the deal, Onconova CEO Steven Fruchtman stated that ON 123300 was a proprietary first in line, cancer-fighting agent. He added that the agent that has a unique action that is likely to improve the clinical outcomes of already approved CDK4/6 inhibitors and that it could help in lowering the growth of the metastatic disease.

    It could also lower the side effects of cancer treatment. He concluded by stating that they were now looking forward to a filling an IND in the U.S by the end of 2020, and that phase 1 studies in the U.S could start in Q1 of 2021.

    This is a big deal because, in case of a breakthrough, it would have a huge impact on the company’s bottom line. The impact would be significantly magnified by the fact that they are working with a Chinese company. As such, a breakthrough would see it benefit from sales in one of the world’s largest markets.

    It is also interesting to note the stock is currently trading at a support level after it dropped following a failed cancer study back in August.

    At its current price level, it is low-risk buy and with the latest news, it is likely to see speculators take positions and bid up the price. This makes it one of the high potential stocks, in the current market environment, when a multitude of factors are creating lots of volatility.

    About Onconova Therapeutics Inc

    Onconova Therapeutics Inc is a biopharma company that develops cancer treatments. It is based in Pennsylvania.

     

  • Two Reasons Why ClearOne Inc [CLRO] is a Perfect Buy at Current Prices

    Two Reasons Why ClearOne Inc [CLRO] is a Perfect Buy at Current Prices

    ClearOne Inc [NASDAQ:CLRO] has over the last few days 0recovered most of the losses from late August and the better part September. From a technical analysis perspective, the stock is at a price level where it can go in any direction. Ideally, the best entry point for this stock would be any price level above $3.

    However, looking at it from a fundamentals perspective, its current price makes for a good entry price as well and has the potential for more gains.  There are a number of factors that likely to drive up bullish sentiment in this stock in the near-term. Some of them are as below:

    Insider buying

    One of the biggest buy signals in the stock markets is insider buying. It usually points to a situation whereby people who have a close relationship with a company have faith in its growth prospects.  A few days ago, ClearOne Inc announced that it had agreed with a group of institutional and accredited investors, Edward Bagley (It’s the largest shareholder), and its CEO Zeynep Hakimoglu for the purchase of 2,116,050 units of common stock at a price of $2.4925 per share.

    In most cases, insider participation leads to an increase in stock as the fundamentals behind such a move start to unveil. In the case of ClearOne, it makes the stock’s current price a perfect entry point, for investors with both short-term and long-term projections for the stock.

    It is also noteworthy that the company intends to use the proceeds of the sale to bolster its working capital. This means that in the near-term, the company is well-positioned to carry out its operations without the risk of running out of money. This is a critical factor that could see it gain in value going into the foreseeable future.

    A patent win

    Back in August, the company announced that the patent trial and appeal board of the U.S and the Trade Mark Office had ruled in its favor in a case against Shure. The company announced that the ruling significantly limited Shure’s 493 patent touching on beamforming microphone arrays.

    This is a technology that was pioneered by ClearOne. The company stated that it believed its products do not infringe on Shure’s patent claims. This win is a big deal and is likely to have a significant impact on the company’s revenues in the long run, and by extension, its stock value.  This further adds weight to this stock’s potential in the long run.

    About ClearOne Inc

    ClearOne Inc designs, makes, and sells networking solutions. It is based in Salt Lake City, Utah.